Combining the power of nature and genomics to create new medicines

News from Demuris

  • Demuris and Newcastle University enter into Funded Collaboration with Morningside Ventures | August 2019
  • Vacancy for Bioinformatic Research Scientist | July 2019
  • Vacancy for Natural Product Chemist | July 2019
  • Vacancy for a Research Associate at Demuris | July 2019
  • Innovate UK Grant to Fund Development of Novel Antibiotics for Drug Resistant TB Awarded to Demuris | May 2019
  • Demuris Receives SBRI Innovate UK Grant to Identify Novel Treatments for Gram Negative Infections | April 2019
  • Demuris and collaborators identify antibiotic with potential to treat Multi-Drug-Resistant Tuberculosis | September 2018
  • Demuris awarded 204,000 grant funding from Innovate UK | March 2018
  • Demuris publication in ACS Chemical Biology | November 2017
  • Professor Jeff Errington awarded the 2017 FEMS-Lwoff Award | September 2017
  • Demuris publication in Journal of Cell Science | September 2017
  • Demuris publication in Journal of Natural Products | April 2017
  • Demuris publication in Nature Microbiology | January 2017
  • Demuris publication in Journal of Natural Product Research | December 2016
  • An extensive portfolio of drug discovery and development programmes | August 2016
  • Demuris awarded 100,000 from Wellcome Trust | June 2016
  • Demuris awarded two grants from Innovate UK | April 2016
  • Demuris awarded 207,000 grant funding from Technology Strategy Board for Synthetic Biology | 20 December 2013
  • Demuris featured in The Times' new service for SME's | 13 May 2013
  • Demuris Director Professor Jeff Errington awarded 2014 Novartis Medal and Prize | March 2013

Demuris Limited
The Biosphere, Draymans Way, Newcastle Helix,
Newcastle upon Tyne, NE4 5BX, UK

Tel: +44 (0)191 580 6177

Email: enquiries@demuris.co.uk

Demuris Limited is registered in England, company number: 06255507

Demuris Limited 2015